Our primary aim was to determine which of the approaches in Table 1 best communicated the basic messages that breast and ovarian cancer risk are higher for medically unmanaged BRCA1 pathogenic variant carriers than for the general population, and that breast cancer is more probable than ovarian cancer. This evidence concerns the gene BRCA1 and breast cancer.